Skip to content

Prognostic Recovery Observations and Guidance for Evaluating Stroke Survivors

Prognostic Recovery Observations and Guidance for Evaluating Stroke Survivors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06465758
Acronym
PROGRESS
Enrollment
360
Registered
2024-06-20
Start date
2024-05-21
Completion date
2029-05-31
Last updated
2024-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke, Functional Recovery, Prognostic Factors

Brief summary

This research delves into the acute prognostic factors influencing functional recovery in individuals who have experienced a stroke. The objective is to describe patterns of functional recovery after a stroke and identify new, clinically significant outcomes or metrics that can serve as predictive indicators for post-stroke functional recovery.

Detailed description

In this prospective observational study with additional procedures, the aim is to describe different patterns of recovery according to clinical characteristics identified during the early phases post stroke. All the additional procedure are functional and clinical tests or questionnaires validated and used for standard stroke clinical practice that pose no risk to the enrolled subject. This study, based at San Raffaele Hospital's stroke unit, will enrol subjects who suffer from stroke assessed in the acute phase (T0), at three-months (T1), six-month (T2) and 1-year post-stroke (T3). No intervention that can interfere with usual clinical practice will be administered between evaluations. Assessments include neurological, neuropsychological and physical therapy questionnaires along with functional tests validated and used in stroke clinical practice.

Interventions

None listed

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * Haemorrhagic or ischaemic stroke confirmed by a clinical diagnosis and by brain imaging * NIHSS item 5-6 ≥1 * 3 to 10 days post-stroke

Exclusion criteria

* Transient ischaemic attack * Premorbid Modified Rankin Scale ≥ 4 * Acute orthopaedic complications * Inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Action Research Arm Test (ARAT)Within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate upper limb functional recovery. The score ranges from 0 (indicating low functional recovery) to 57 (high functional recovery).

Secondary

MeasureTime frameDescription
Modified Rankin Scale (MRS)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate global disability. The score ranges from 0 (indicating no symptoms) to 6 (indicating deceased).
Fugl-Meyer Assessment for upper and lower limb (FMA- UL and LL)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate motor function in the upper and lower limbs. The motor score ranges from 0 (indicating hemiplegia) to 100 points (representing normal motor performance) with 66 points allocated for the upper extremity and 34 points for the lower extremity.
Montreal Cognitive Assessment (MOCA)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate cognitive functions. Scores range from 0 to 30. Higher scores indicate better cognitive functions.
Hospital Anxiety and Depression Scale (HADS)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate levels of anxiety and depression. Scores range from 0 (normal) to 21 (abnormal).
Barthel Index (BI)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate activities of daily living. The score ranges from 0 (complete dependency) to 100 (complete independency).
Motricity Index (MI)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess motor impairment. The score ranges from 0 to 100, with higher scores indicating lower motor impairment.
Ashworth Scale (AS)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate spasticity. The scoring system ranges from 0 to 4, with higher scores indicating increased spasticity.
Functional Ambulation Classification (FAC)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate walking ability (independence). Score ranges from 0 (non-functional ambulation) to 5 (independent ambulation).
ABILHANDAssessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess manual ability. Scoring: Patients are prompted to assess their perceived difficulty in task performance. Scores range from 0 (impossible to perform) to 46 (easy to perform). Higher scores indicate better manual ability.
Trunk Control Test (TCT)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess trunk and postural control. Scoring: points are earned based on performance in mobility tasks. Score ranges from 0 to 100. Higher scores reflect better trunk and postural control.
Mini Balance Evaluation Test (Mini-BESTest)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess transitions/anticipatory postural control, reactive postural control, sensory orientation and stability in gait. Scoring: points are awarded for performing balance tasks. Higher scores indicate better performance.
Timed Up and Go Test (TUG)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess mobility and dynamic balance. Scoring: time (seconds) taken to perform a mobility task. More time corresponds to worse performance.
10 Meters Walking Test (10MWT)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess gait speed. Scoring: time (seconds) to walk 10 meters. More time corresponds to worse performance.
6 Minutes Walking Test (6MWT)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo assess walking endurance. Scoring: distance (meters) walked in 6 minutes. More meters indicate better performance.
Medical Research Council Scale (MRC)Assessments will occur within 3-10 days post stroke and at the three-month, six-month and one-year follow-upTo evaluate muscle strength. The score ranges from 0 (indicating no muscle contraction) to 5 (normal muscle power). Higher scores indicate greater strength.

Countries

Italy

Contacts

Primary ContactRaffaella Chieffo, MD, PhD
chieffo.raffaella@hsr.it0226432755
Backup ContactElisabetta Sarasso, MSc, PT
sarasso.elisabetta@hsr.it0226433051

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026